002004 华邦健康
已收盘 09-27 15:00:00
资讯
新帖
简况
渝股半年报丨华邦健康旅游收入增320% 旗下秦岭旅游有望上市
上游新闻 · 08-30
渝股半年报丨华邦健康旅游收入增320% 旗下秦岭旅游有望上市
华邦健康(002004.SZ)发半年度业绩,净利润3.87亿元,同比减少30.86%
智通财经网 · 08-28
华邦健康(002004.SZ)发半年度业绩,净利润3.87亿元,同比减少30.86%
华邦健康(002004.SZ)控股子公司凯盛新材向不特定对象发行可转债申请获得深交所上市审核委员会审议通过
智通财经网 · 06-30
华邦健康(002004.SZ)控股子公司凯盛新材向不特定对象发行可转债申请获得深交所上市审核委员会审议通过
华邦健康(002004)股东西藏汇邦科技有限公司质押3050.7万股,占总股本1.54%
证券之星 · 06-02
华邦健康(002004)股东西藏汇邦科技有限公司质押3050.7万股,占总股本1.54%
华邦健康:谱新生物已于近期完成A轮融资,目前公司持股比例为8.9934%
证券之星 · 05-09
华邦健康:谱新生物已于近期完成A轮融资,目前公司持股比例为8.9934%
华邦健康:第一,受客观环境以及市场竞争影响,汉江药业22年营收和净利润较去年同期有小幅下降
证券之星 · 05-09
华邦健康:第一,受客观环境以及市场竞争影响,汉江药业22年营收和净利润较去年同期有小幅下降
华邦健康:公司发生的关联交易严格按照深交所相关规定履行审批程序和信息披露义务
证券之星 · 04-28
华邦健康:公司发生的关联交易严格按照深交所相关规定履行审批程序和信息披露义务
华邦健康(002004)4月27日主力资金净卖出1076.13万元
证券之星 · 04-28
华邦健康(002004)4月27日主力资金净卖出1076.13万元
图解华邦健康年报:第四季度单季净利润同比减292.75%
证券之星 · 04-26
图解华邦健康年报:第四季度单季净利润同比减292.75%
华邦健康最新公告:一季度净利增5.05%至1.77亿元
证券之星 · 04-26
华邦健康最新公告:一季度净利增5.05%至1.77亿元
华邦健康(002004.SZ)发布一季度业绩,净利润1.77亿元,增长5.05%
智通财经 · 04-26
华邦健康(002004.SZ)发布一季度业绩,净利润1.77亿元,增长5.05%
华邦健康(002004.SZ)发布2022年度业绩,净利润4.33亿元,下降35.12%,拟10股派2.2元
智通财经 · 04-26
华邦健康(002004.SZ)发布2022年度业绩,净利润4.33亿元,下降35.12%,拟10股派2.2元
华邦健康:公司深耕皮肤行业三十年,是皮肤临床用药及皮肤健康领域领先企业
证券之星 · 04-14
华邦健康:公司深耕皮肤行业三十年,是皮肤临床用药及皮肤健康领域领先企业
丽江股份(002033.SZ)股东华邦健康解除质押3900万股
智通财经 · 04-05
丽江股份(002033.SZ)股东华邦健康解除质押3900万股
加载更多
公司概况
公司名称:
华邦生命健康股份有限公司
所属行业:
化学原料和化学制品制造业
上市日期:
2004-06-25
主营业务:
华邦生命健康股份有限公司的主营业务为医药及农化、新材料产品的研发、生产、销售,医疗服务、旅游投资及运营业务。公司的主要产品乐夫松、必亮、为豆、维夫欣、力克肺疾、明希欣、速瑞、斯瑞、常罗定、瑞婷、开顺、必与、汉非、海格力、乙氧氟草醚、硝磺草酮、嘧菌酯、噻嗪酮、氟苯等。公司凭借强大的自主登记能力取得多个农药登记证,快速打开市场,先发优势突出。在国内市场,公司拥有的农药产品登记证数量位于领先地位。
发行价格:
9.60
{"stockData":{"symbol":"002004","market":"SZ","secType":"STK","nameCN":"华邦健康","latestPrice":5.02,"timestamp":1695798228000,"preClose":5.02,"halted":0,"volume":8439908,"delay":0,"floatShares":1882000000,"shares":1980000000,"eps":0.1316,"marketStatus":"已收盘","marketStatusCode":5,"change":0,"latestTime":"09-27 15:00:00","open":5.01,"high":5.05,"low":5.01,"amount":42435000,"amplitude":0.008,"askPrice":5.02,"askSize":2,"bidPrice":5.01,"bidSize":2615,"shortable":0,"etf":0,"ttmEps":0.1316,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1695864600000},"adr":0,"adjPreClose":5.02,"symbolType":"stock","highLimit":5.52,"lowLimit":4.52,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1979919191,"pbRate":0.98,"roa":"--","roe":"3.72%","epsLYR":0.2188,"committee":-0.481728,"marketValue":9939000000,"floatMarketCap":9449000000,"peRate":38.145895,"changeRate":0,"turnoverRate":0.0045,"status":2},"requestUrl":"/m/hq/s/002004","defaultTab":"news","newsList":[{"id":"2363445968","title":"渝股半年报丨华邦健康旅游收入增320% 旗下秦岭旅游有望上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2363445968","media":"上游新闻","top":-1,"share":"https://www.laohu8.com/m/news/2363445968?lang=zh_cn&edition=full","pubTime":"2023-08-30 09:44","pubTimestamp":1693359840,"startTime":"0","endTime":"0","summary":"报告显示,旅游服务业营收5.21亿元,同比大增320.81%。业内人士指出,华邦健康旗下秦岭旅游有望上市。2023年上半年,秦岭旅游其下属的交通公司实现营业收入1575.97万元,目前该交通公司执行的为半价票,一旦适当提高或者恢复原有票价,交通公司将大幅提高营收和利润水平,为秦岭旅游上市再增业绩。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2023-08-30/doc-imzixsii8349076.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2023-08-30/doc-imzixsii8349076.shtml","is_publish_highlight":false},{"id":"2362122310","title":"华邦健康(002004.SZ)发半年度业绩,净利润3.87亿元,同比减少30.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2362122310","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2362122310?lang=zh_cn&edition=full","pubTime":"2023-08-28 19:51","pubTimestamp":1693223460,"startTime":"0","endTime":"0","summary":"华邦健康(002004.SZ)发布2023年半年度报告,营业收入58.69亿元,同比减少12.40%。归属于上市公司股东的净利润3.87亿元,同比减少30.86%。归属于上市公司股东的扣除非经常性损益的净利润3.77亿元,同比减少32.37%。基本每股收益0.1955元。\n\n现在送您60元福利红包,直接提现不套路~~~快来参与活动吧!\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-08-28/doc-imziufrc9139672.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-08-28/doc-imziufrc9139672.shtml","is_publish_highlight":false},{"id":"2347990396","title":"华邦健康(002004.SZ)控股子公司凯盛新材向不特定对象发行可转债申请获得深交所上市审核委员会审议通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2347990396","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2347990396?lang=zh_cn&edition=full","pubTime":"2023-06-30 12:06","pubTimestamp":1688097960,"startTime":"0","endTime":"0","summary":"华邦健康(002004.SZ)公告,深圳证券交易所上市审核委员会于2023年6月29日召开了2023年第48次上市审核委员会审议会议,对公司控股子公司山东凯盛新材料股份有限公司(“凯盛新材”)向不特定对象发行可转换公司债券的申请进行了审议。根据会议审议结果,凯盛新材本次发行的申请符合发行条件、上市条件和信息披露要求。\n\n炒股开户享福利,送投顾服务60天体验权,一对一指导服务!\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-06-30/doc-imyyzutu8903373.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-06-30/doc-imyyzutu8903373.shtml","is_publish_highlight":false},{"id":"2340733717","title":"华邦健康(002004)股东西藏汇邦科技有限公司质押3050.7万股,占总股本1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2340733717","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2340733717?lang=zh_cn&edition=full","pubTime":"2023-06-02 21:24","pubTimestamp":1685712287,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023060200035635.shtml","is_publish_highlight":false},{"id":"2334174352","title":"华邦健康:谱新生物已于近期完成A轮融资,目前公司持股比例为8.9934%","url":"https://stock-news.laohu8.com/highlight/detail?id=2334174352","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2334174352?lang=zh_cn&edition=full","pubTime":"2023-05-09 17:13","pubTimestamp":1683623597,"startTime":"0","endTime":"0","summary":"华邦健康05月09日在投资者关系平台上答复了投资者关心的问题。华邦健康董秘:投资者您好,谱新生物已于近期完成A轮融资,目前公司持股比例为8.9934%。华邦健康2023一季报显示,公司主营收入29.76亿元,同比下降12.46%;归母净利润1.77亿元,同比上升5.05%;扣非净利润1.69亿元,同比上升4.78%;负债率44.27%,投资收益1000.05万元,财务费用1.02亿元,毛利率38.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023050900025266.shtml","is_publish_highlight":false},{"id":"2334260067","title":"华邦健康:第一,受客观环境以及市场竞争影响,汉江药业22年营收和净利润较去年同期有小幅下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2334260067","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2334260067?lang=zh_cn&edition=full","pubTime":"2023-05-09 09:59","pubTimestamp":1683597599,"startTime":"0","endTime":"0","summary":"第一2022年公司医药板块里汉江药业营收及利润下滑的原因。第三松山医院营收及利润,康复医院营收及亏损情况。谢谢华邦健康董秘:投资者您好,第一,受客观环境以及市场竞争影响,汉江药业22年营收和净利润较去年同期有小幅下降。华邦健康2023一季报显示,公司主营收入29.76亿元,同比下降12.46%;归母净利润1.77亿元,同比上升5.05%;扣非净利润1.69亿元,同比上升4.78%;负债率44.27%,投资收益1000.05万元,财务费用1.02亿元,毛利率38.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023050900012769.shtml","is_publish_highlight":false},{"id":"2330529410","title":"华邦健康:公司发生的关联交易严格按照深交所相关规定履行审批程序和信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2330529410","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2330529410?lang=zh_cn&edition=full","pubTime":"2023-04-28 20:21","pubTimestamp":1682684517,"startTime":"0","endTime":"0","summary":"公司发生的关联交易严格按照深交所相关规定履行审批程序和信息披露义务。经评估,百盛药业流通业务包含商誉的资产组可回收金额为3870.24万元,可回收金额低于其账面价值,故本期计提归属于本公司应确认的商誉减值损失 4.56亿元。华邦健康2023一季报显示,公司主营收入29.76亿元,同比下降12.46%;归母净利润1.77亿元,同比上升5.05%;扣非净利润1.69亿元,同比上升4.78%;负债率44.27%,投资收益1000.05万元,财务费用1.02亿元,毛利率38.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023042800041233.shtml","is_publish_highlight":false},{"id":"2330560219","title":"华邦健康(002004)4月27日主力资金净卖出1076.13万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2330560219","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2330560219?lang=zh_cn&edition=full","pubTime":"2023-04-28 09:29","pubTimestamp":1682645345,"startTime":"0","endTime":"0","summary":"截至2023年4月27日收盘,华邦健康报收于5.23元,下跌3.86%,换手率2.28%,成交量42.94万手,成交额2.25亿元。近5日资金流向一览见下表:华邦健康融资融券信息显示,融资方面,当日融资买入3111.42万元,融资偿还1430.06万元,融资净买入1681.36万元。根据近五年财报数据,证券之星估值分析工具显示,华邦健康行业内竞争力的护城河一般,盈利能力较差,营收成长性一般。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023042800015667.shtml","is_publish_highlight":false},{"id":"2330694643","title":"图解华邦健康年报:第四季度单季净利润同比减292.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2330694643","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2330694643?lang=zh_cn&edition=full","pubTime":"2023-04-26 18:37","pubTimestamp":1682505451,"startTime":"0","endTime":"0","summary":"华邦健康2022年报显示,公司主营收入132.32亿元,同比上升6.45%;归母净利润4.33亿元,同比下降35.12%;扣非净利润4.09亿元,同比下降32.77%;其中2022年第四季度,公司单季度主营收入30.51亿元,同比下降19.74%;单季度归母净利润-2.84亿元,同比下降292.75%;单季度扣非净利润-2.92亿元,同比下降313.49%;负债率44.88%,投资收益4.41亿元,财务费用2.07亿元,毛利率40.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023042600033253.shtml","is_publish_highlight":false},{"id":"2330637363","title":"华邦健康最新公告:一季度净利增5.05%至1.77亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2330637363","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2330637363?lang=zh_cn&edition=full","pubTime":"2023-04-26 17:50","pubTimestamp":1682502601,"startTime":"0","endTime":"0","summary":"华邦健康公布2023年一季度报告,报告期营业收入29.76亿元,同比下降12.46%;归属于上市公司股东的净利润1.77亿元,同比增长5.05%;基本每股收益0.0895元。截至2023年4月26日收盘,华邦健康报收于5.44元,上涨0.93%,换手率0.72%,成交量13.55万手,成交额7358.33万元。根据近五年财报数据,证券之星估值分析工具显示,华邦健康行业内竞争力的护城河良好,盈利能力较差,营收成长性较差。以上内容由证券之星根据公开信息整理,与本站立场无关。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023042600031267.shtml","is_publish_highlight":false},{"id":"2330368511","title":"华邦健康(002004.SZ)发布一季度业绩,净利润1.77亿元,增长5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2330368511","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2330368511?lang=zh_cn&edition=full","pubTime":"2023-04-26 17:36","pubTimestamp":1682501775,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华邦健康(002004.SZ)发布2023年第一季度报告,该公司营业收入为29.76亿元,同比减少12.46%。归属于上市公司股东的净利润为1.77亿元,同比增长5.05%。归属于上市公司股东的扣除非经常性损益的净利润为1.69亿元,同比增长4.78%。基本每股收益为0.0895元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/919491.html","is_publish_highlight":false},{"id":"2330368303","title":"华邦健康(002004.SZ)发布2022年度业绩,净利润4.33亿元,下降35.12%,拟10股派2.2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2330368303","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2330368303?lang=zh_cn&edition=full","pubTime":"2023-04-26 17:34","pubTimestamp":1682501658,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华邦健康(002004.SZ)发布2022年年度报告,该公司营业收入为132.32亿元,同比增长6.45%。归属于上市公司股东的净利润为4.33亿元,同比减少35.12%。归属于上市公司股东的扣除非经常性损益的净利润为4.09亿元,同比减少32.77%。基本每股收益为0.2188元。此外,拟向全体股东每10股派发现金红利2.2元(含税)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/919485.html","is_publish_highlight":false},{"id":"2327194151","title":"华邦健康:公司深耕皮肤行业三十年,是皮肤临床用药及皮肤健康领域领先企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2327194151","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2327194151?lang=zh_cn&edition=full","pubTime":"2023-04-14 10:43","pubTimestamp":1681440226,"startTime":"0","endTime":"0","summary":"公司深耕皮肤行业三十年,是皮肤临床用药及皮肤健康领域领先企业。目前公司依托在技术研发、产品覆盖、渠道布局等方面均奠定的优势,正在积极有序地发展泛皮肤健康业务。华邦健康董秘:投资者您好,公司2022年年度报告披露时间因编制进度和审计进度推迟。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2023041400016416.shtml","is_publish_highlight":false},{"id":"2325357735","title":"丽江股份(002033.SZ)股东华邦健康解除质押3900万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2325357735","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2325357735?lang=zh_cn&edition=full","pubTime":"2023-04-05 16:36","pubTimestamp":1680683813,"startTime":"0","endTime":"0","summary":"智通财经APP讯,丽江股份(002033.SZ)公告,公司股东华邦健康所持有公司部分股份已于2023年4月3日办理了解除质押手续,本次解除质押3900万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/906669.html","is_publish_highlight":false}],"profile":{"ret":0,"listingDate":"2004-06-25","address":"重庆市渝北区人和星光大道69号","stockEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":0.0183},{"period":"3month","weight":0.0266},{"period":"6month","weight":-0.0667},{"period":"1year","weight":-0.0411},{"period":"ytd","weight":0.0285}],"companyName":"华邦生命健康股份有限公司","boardCode":"AI0026","perCapita":"21692股","boardName":"化学原料和化学制品制造业","registeredCapital":"197991万元","compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":0.0028},{"period":"3month","weight":-0.0236},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0043},{"period":"ytd","weight":0.0058}],"survey":" 华邦生命健康股份有限公司的主营业务为医药及农化、新材料产品的研发、生产、销售,医疗服务、旅游投资及运营业务。公司的主要产品乐夫松、必亮、为豆、维夫欣、力克肺疾、明希欣、速瑞、斯瑞、常罗定、瑞婷、开顺、必与、汉非、海格力、乙氧氟草醚、硝磺草酮、嘧菌酯、噻嗪酮、氟苯等。公司凭借强大的自主登记能力取得多个农药登记证,快速打开市场,先发优势突出。在国内市场,公司拥有的农药产品登记证数量位于领先地位。","serverTime":1695860574270,"listedPrice":9.6,"stockholders":"86771人(较上一季度减少46.18%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.17.2","shortVersion":"4.17.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华邦健康(002004)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华邦健康(002004)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华邦健康,002004,华邦健康股票,华邦健康股票老虎,华邦健康股票老虎国际,华邦健康行情,华邦健康股票行情,华邦健康股价,华邦健康股市,华邦健康股票价格,华邦健康股票交易,华邦健康股票购买,华邦健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华邦健康(002004)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华邦健康(002004)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}